Aeterna Zentaris Inc - Company Profile
Powered by 
All the data and insights you need on Aeterna Zentaris Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Aeterna Zentaris Inc Strategy Report
- Understand Aeterna Zentaris Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Aeterna Zentaris Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| CN111684283B | Grant | 通过含马昔瑞林的组合物评估人生长激素缺乏症的方法 | G01N2333/61; G01N33/74; G01N2800/048; G01N33/49; G01N33/5091 | February 09, 2024 |
| KR102635025B1 | Grant | 마시모렐린을 사용하여 소아 환자의 성장 호르몬 결핍증을 진단하는 스크리닝 방법 | G01N2333/61; G01N33/5091; G01N33/74 | February 07, 2024 |
| CA3086079C | Grant | Method of assessing growth hormone deficiency in humans by a macimorelin containing composition | G01N33/74; G01N33/49; G01N2800/048; G01N2333/61; G01N33/5091 | July 18, 2023 |
| NZ764338A | Application | Method of assessing growth hormone deficiency in humans by a macimorelin containing composition | G01N33/49; G01N33/74; G01N2333/61; G01N33/5091; G01N2800/048 | June 30, 2023 |
| EP4185866A1 | Application | Screening-verfahren zur diagnose von wachstumshormonmangel bei pädiatrischen patienten unter verwendung von macimorelin | G01N2333/61; G01N33/5091; G01N33/74 | May 31, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer